Lettuce Seeds Beat Insomnia in Randomized Trial — Here's What the Research Shows
A compound in lettuce called lactucin shows real sleep benefits. A double-blind trial found lettuce seed oil helped 70% of insomniacs improve within a week.
Summary
Lettuce contains a natural sedative compound called lactucin, responsible for its slightly bitter taste. A randomized, double-blind, placebo-controlled trial found that lettuce seed oil helped roughly 70% of older adults with insomnia report significant improvement within one week, compared to just 20% in the placebo group. The research builds on animal studies showing romaine lettuce enhances sleep in mice and rats. This matters because poor sleep — defined as under seven hours nightly — is linked to a 12–35% increased risk of premature death, impaired artery function comparable to smoking or diabetes, and changes in the expression of over 700 genes. Lettuce seed oil may offer a safe, natural alternative for those who struggle to sleep despite good sleep hygiene practices.
Detailed Summary
Sleep deprivation is a serious and underappreciated health threat. Getting fewer than seven hours per night is associated with a 12–35% increased risk of premature death, and even a single week of five-hour nights can impair artery function to a degree comparable to smoking or having coronary artery disease. Despite this, roughly 28% of American adults routinely fall short of the recommended sleep duration. Finding safe, effective, non-pharmaceutical sleep aids remains an important goal for health optimization.
Lettuce — the common salad green Lactuca sativa — has been used as a sedative since the Roman Empire. Its hypnotic properties come from lactucin, a bitter compound concentrated especially in romaine varieties. Animal studies have confirmed that romaine lettuce extracts enhance sleep in both mice and rats, providing a biological rationale for investigating human applications.
A randomized, double-blind, placebo-controlled trial tested lettuce seed oil — an extract derived from lettuce seeds — in older adults with insomnia. The results were striking: approximately 70% of participants receiving the lettuce seed oil reported their insomnia as "very much or much improved" after one week, compared to only 20% in the placebo group. The researchers concluded the intervention was a useful and safe sleeping aid for geriatric patients.
The findings carry particular relevance for populations where pharmaceutical sleep aids pose risks. Conventional sleeping medications can have significant side effects, and their safety during pregnancy is a concern, given that sleep disturbances affect up to 80% of women during pregnancy. Natural dietary approaches like lettuce seed oil may offer a gentler option worth exploring.
Important caveats apply: the article summarizes rather than presents primary data, the trial population was limited to older adults, and the article was truncated. Readers should seek the full published study and consult a clinician before using lettuce seed oil as a sleep intervention.
Key Findings
- Lettuce seed oil helped ~70% of insomniacs improve significantly within one week versus 20% on placebo.
- Lactucin, lettuce's bitter compound, is the active hypnotic agent; romaine has the highest concentration.
- Sleeping under seven hours nightly raises premature death risk by 12–35% and impairs artery function.
- Just one week of five-hour nights causes endothelial dysfunction comparable to smoking or diabetes.
- Lettuce seed oil was rated safe and useful for older adults, a group with high insomnia prevalence.
Methodology
This is a research summary article by physician Michael Greger M.D. referencing a published randomized, double-blind, placebo-controlled trial on lettuce seed oil. NutritionFacts.org is a non-profit evidence-based platform, though it reflects a plant-forward editorial perspective. The article was truncated, limiting full assessment of cited sources.
Study Limitations
The article is incomplete as published, cutting off mid-sentence, so the full scope of evidence and safety data could not be assessed. The primary trial focused on geriatric patients, limiting generalizability to younger adults. Readers should locate the original peer-reviewed study to evaluate sample size, methodology, and long-term safety data independently.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: